| Year |
Citation |
Score |
| 2017 |
Terryah ST, Fellner RC, Ahmad S, Moore PJ, Reidel B, Sesma JI, Kim CS, Garland AL, Scott DW, Sabater JR, Carpenter J, Randell SH, Kesimer M, Abraham WM, Arendshorst WJ, et al. Evaluation of a SPLUNC1-Derived Peptide for the Treatment of Cystic Fibrosis Lung Disease. American Journal of Physiology. Lung Cellular and Molecular Physiology. ajplung.00546.2016. PMID 28982737 DOI: 10.1152/Ajplung.00546.2016 |
0.409 |
|
| 2016 |
Fellner RC, Moss NG, Goy MF. Dietary salt regulates uroguanylin expression and signaling activity in the kidney, but not in the intestine. Physiological Reports. 4. PMID 27185905 DOI: 10.14814/Phy2.12782 |
0.688 |
|
| 2016 |
Fellner RC, Terryah ST, Tarran R. Inhaled protein/peptide-based therapies for respiratory disease. Molecular and Cellular Pediatrics. 3: 16. PMID 27098663 DOI: 10.1186/S40348-016-0044-8 |
0.329 |
|
| 2015 |
Fellner RC, Guan Z, Cook AK, Pollock DM, Inscho EW. Endothelin contributes to blunted renal autoregulation observed with a high-salt diet. American Journal of Physiology. Renal Physiology. 309: F687-96. PMID 26246513 DOI: 10.1152/Ajprenal.00641.2014 |
0.41 |
|
| 2014 |
Fellner RC, Cook AK, O'Connor PM, Zhang S, Pollock DM, Inscho EW. High-salt diet blunts renal autoregulation by a reactive oxygen species-dependent mechanism American Journal of Physiology - Renal Physiology. 307: F33-F40. PMID 24872316 DOI: 10.1152/Ajprenal.00040.2014 |
0.388 |
|
| 2014 |
Guan Z, Fellner RC, Van Beusecum J, Inscho EW. P2 receptors in renal autoregulation. Current Vascular Pharmacology. 12: 818-28. PMID 24066935 DOI: 10.2174/15701611113116660152 |
0.403 |
|
| 2011 |
Qian X, Moss NG, Fellner RC, Taylor-Blake B, Goy MF. The rat kidney contains high levels of prouroguanylin (the uroguanylin precursor) but does not express GC-C (the enteric uroguanylin receptor). American Journal of Physiology. Renal Physiology. 300: F561-73. PMID 21106860 DOI: 10.1152/Ajprenal.00282.2010 |
0.692 |
|
| 2010 |
Moss NG, Riguera DA, Fellner RC, Cazzolla C, Goy MF. Natriuretic and antikaliuretic effects of uroguanylin and prouroguanylin in the rat. American Journal of Physiology. Renal Physiology. 299: F1433-42. PMID 20861080 DOI: 10.1152/Ajprenal.00281.2010 |
0.649 |
|
| 2008 |
Qian X, Moss NG, Fellner RC, Goy MF. Circulating prouroguanylin is processed to its active natriuretic form exclusively within the renal tubules. Endocrinology. 149: 4499-509. PMID 18499761 DOI: 10.1210/En.2007-1724 |
0.694 |
|
| 2008 |
Moss NG, Fellner RC, Qian X, Yu SJ, Li Z, Nakazato M, Goy MF. Uroguanylin, an intestinal natriuretic peptide, is delivered to the kidney as an unprocessed propeptide. Endocrinology. 149: 4486-98. PMID 18499760 DOI: 10.1210/En.2007-1725 |
0.695 |
|
| Show low-probability matches. |